Reuters logo
AbbVie drops drug secrecy case against EU agency
April 3, 2014 / 4:30 PM / 3 years ago

AbbVie drops drug secrecy case against EU agency

LONDON, April 3 (Reuters) - AbbVie, one of the two U.S. firms bringing an injunction against Europe’s drugs regulator over the issue of trial data secrecy, said on Thursday it had withdrawn its lawsuit.

AbbVie, a pharmaceutical company, had sought an injunction in March last year to block Europe’s medicines regulator from releasing “confidential” and “commercially-sensitive” information on its blockbuster rheumatoid arthritis drug.

AbbVie said on Thursday the European Medicines Agency had accepted a new set of redacted documents submitted by the company, along with the company’s rationale for removing certain confidential information.

As a result, AbbVie withdrew its lawsuit.

The lawsuit against AbbVie and another U.S. drugmaker InterMune had turned into a high-profile fight over drug trial data.

Researchers and patient groups want access to this raw data to improve third-party scrutiny and stress-test claims about drugs. But many companies fear that this will damage their businesses and undermine the ability to defend patents.

Reporting by Kate Holton. Editing by Jane Merriman

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below